Milestone Scientific (MLSS) Cash from Investing Activities (2010 - 2026)
Milestone Scientific (MLSS) reported Cash from Investing Activities of -$1632.0 for Q1 2026, down 25.15% on a YoY basis from -$2180.5 in Q1 2025, and up 47.63% sequentially from -$3116.0 in Q4 2025.
Milestone Scientific (MLSS) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Milestone Scientific (MLSS) has 17 years of Cash from Investing Activities data on file, last reported at -$1632.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 25.15% year-over-year to -$1632.0; the trailing twelve-month figure through Mar 2026 stood at -$15452.0 (down 101.61% YoY), and the FY2025 full-year result was -$15124.0, down 100.51% from the prior year.
- Cash from Investing Activities grew to -$1632.0 in Q1 2026, from -$3116.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $2.4 million in Q2 2023 to a low of -$4.4 million in Q1 2023.
- A 5-year average of -$2067.1 and a median of -$3528.0 in 2024 frame the typical range for Cash from Investing Activities.
- Peak annual rise in Cash from Investing Activities reached 2881311.76% in 2023, while the deepest fall reached 12054.75% in 2023.
- Tracing MLSS's Cash from Investing Activities over 5 years: stood at -$4700.0 in 2022, then tumbled by 10842.6% to -$514302.0 in 2023, then jumped by 99.31% to -$3528.0 in 2024, then gained by 11.68% to -$3116.0 in 2025, then soared by 47.63% to -$1632.0 in 2026.
- Business Quant data shows MLSS's Cash from Investing Activities at -$1632.0 in Q1 2026, -$3116.0 in Q4 2025, and -$6232.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | -218.00 Mn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -77.00 Mn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Milestone Scientific | 35.28 Mn | 33.63 Mn | 1.56 Mn | -1,632.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,632.00 |
| Mar 31, 2026 | -1,632.00 |
| Dec 31, 2025 | -3,116.00 |
| Dec 31, 2025 | -3,116.00 |
| Sep 30, 2025 | -6,232.00 |
| Sep 30, 2025 | -6,232.00 |
| Jun 30, 2025 | -4,472.00 |
| Jun 30, 2025 | -4,472.00 |
| Mar 31, 2025 | -1,304.00 |
| Mar 31, 2025 | -1,304.00 |
| Dec 31, 2024 | -3,528.00 |
| Dec 31, 2024 | -3,528.00 |
| Jun 30, 2024 | 965,514.00 |
| Jun 30, 2024 | 965,514.00 |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | -514,302.00 |
| Dec 31, 2023 | -514,302.00 |
| Sep 30, 2023 | -475,494.00 |
| Sep 30, 2023 | -475,494.00 |